Sore Throat Relief Spray
NDC Package 68016-342-06
Package Information
Sore Throat Relief (phenol) sprays is Adults and children 6 years of age and older: Children under 12 years of age should be supervised in the use of this product Children under 6 years of age: consult a doctor or dentist•Apply to the affected area (one spray)•Allow to remain in place for at least 15 seconds, then spit out•Use every 2 hours or as directed by a doctor Children under 12 years of age should be supervised in the use of this product Children under 6 years of age: consult a doctor or dentist. This formulation utilizes a spray delivery system. Marketed by Chain Drug Consortium, this product is identified by NDC 68016-342 and is authorized under FDA application M022.
Identification & Billing
- RxCUI: 198776 - phenol 1.4 % Mucosal Spray
- RxCUI: 198776 - phenol 14 MG/ML Mucosal Spray
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68016 - Chain Drug Consortium
- 68016-342 - Sore Throat Relief
- 68016-342-06 - 177 mL in 1 BOTTLE, SPRAY
- 68016-342 - Sore Throat Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68016-342-06 identifies a specific commercial package of 177 ml in 1 bottle, spray of Sore Throat Relief Cherry Flavor, a human over the counter drug labeled by Chain Drug Consortium. This spray is formulated for oral use and contains phenol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chain Drug Consortium on December 31, 2014. The current certification is valid through December 31, 2026.
How is this Chain Drug Consortium product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68016034206. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.